查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1941846

北美靜脈輸液治療市場規模、佔有率和趨勢分析報告：按服務、組件、提供者類型、最終用途、國家和細分市場預測（2026-2033 年）

North America IV Hydration Therapy Market Size, Share & Trends Analysis Report By Service (Immune Boosters, Energy Boosters), By Component (Medicated, Non-medicated), By Provider Type, By End Use, By Country, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

北美靜脈輸液治療市場概況

預計到 2025 年，北美靜脈輸液療法的市場規模將達到 13.5 億美元，預計到 2033 年將達到 25.6 億美元。

預計從 2026 年到 2033 年，該市場將以 8.6% 的複合年成長率成長。推動該市場成長的主要因素是消費者對積極健康管理的興趣日益濃厚、向預防性健康理念的轉變以及對便捷、按需醫療保健服務的需求不斷成長。

疫情後人們健康意識的提高顯著加速了靜脈輸液作為一種生活方式和復健方法的普及。同時，隨著疲勞、偏頭痛和營養不良等疾病發生率的增加，靜脈輸液療法的治療範圍也正在超越其傳統的臨床應用。

隨著癌症、糖尿病等慢性疾病的日益普遍，北美地區的靜脈輸液治療產業也持續成長。根據美國疾病管制與預防中心（CDC）2024年2月的估計，美國約有1.29億人患有至少一種重大慢性疾病，使得對有效醫療解決方案的需求激增。靜脈輸液治療作為一種直接、快速的手段，在應對和控制慢性疾病的影響方面發揮著至關重要的作用。它正逐漸成為改善慢性病患者健康狀況的重要工具。隨著慢性病盛行率的上升，市場也不斷擴大，為有需要的患者提供專業的照護和支援。

北美地區對靜脈輸液療法益處的認知不斷提高，正在推動市場成長。英國國家健康與臨床最佳化研究所 (NICE) 指出，許多成年患者需要接受靜脈輸液療法來調節體液和電解質平衡。靜脈輸液療法是治療性介入，旨在補充體液並恢復身體功能。值得注意的是，由於它繞過了消化器官系統，因此與口服給藥相比，維生素、電解質和抗氧化劑的吸收速度更快、更充分。

靜脈輸液療法廣泛應用於多個臨床領域，以確保快速有效地進行體液和電解質管理。在急診和重症監護中，它能為創傷、休克、敗血症和急性脫水患者提供即時復甦。在胃腸道疾病中，它有助於控制因嚴重嘔吐、腹瀉或發炎性腸道疾病引起的體液流失。在術後護理中，靜脈輸液療法用於維持體液平衡、給藥，並在口服攝取受限的情況下支持患者復健。在腫瘤科，它能預防化療和放療期間的脫水和疲勞。在慢性病管理中，它能為口服攝取受限的糖尿病、腎臟病和心血管疾病患者提供支援。

靜脈輸液療法的需求日益成長，也推動了便利、個人化健康管理方案的興起，這些方案超越了傳統的臨床照護。例如，2025年8月，AquaPulse IV在維吉尼亞弗雷德里克斯堡推出了行動靜脈輸液服務。這項服務由合格的醫療保健專業人員提供客製化的補充液體和維生素輸液，直接送到患者家中、職場和活動場所。這項發展表明，靜脈輸液療法正逐漸成為生活方式和預防保健的重要組成部分，能夠在無縫融入日常生活的環境中，幫助患者快速恢復、增強活力並提升免疫力。這些按需服務模式凸顯了健康服務領域對便利性和以病人為中心的照護日益成長的關注。

目錄

第1章：調查方法和範圍

第2章執行摘要

第3章 市場變數、趨勢與範圍

  • 市場趨勢展望
  • 市場動態
  • 商業環境分析
    • 波特五力分析
    • PESTLE分析

第4章：北美靜脈輸液治療市場：服務估算與趨勢分析

  • 服務市佔率變化分析（2025 年和 2033 年）
  • 按服務分類的市場規模、預測和趨勢分析（2021-2033 年）
  • 免疫增強劑
  • 能量增強劑
  • 水合作用
  • 美與美學
  • 排毒
  • 長壽與抗老
  • 運動能力和競技水平
  • 緩解偏頭痛
  • 壓力、睡眠和情緒支持
  • 流感和腸胃炎
  • 其他

第5章 北美靜脈輸液治療市場：依成分分類的估算與趨勢分析

  • 按組成部分分類的市佔率波動分析（2025 年和 2033 年）
  • 按組件分類的市場規模、預測和趨勢分析（2021年至2033年）
  • 含有藥物成分
  • 非藥用

第6章 北美靜脈輸液治療市場：按服務提供者類型分類的估算和趨勢分析

  • 提供者類型儀表板
  • 按供應商類型分類的市佔率波動分析（2025 年和 2033 年）
  • 按供應商類型分類的市場規模、預測和趨勢分析（2021-2033 年）
  • 行動電信商
  • 實體提供者

第7章 北美靜脈輸液治療市場：依最終用途分類的估算與趨勢分析

  • 按最終用途分類的市佔率變化分析（2025 年和 2033 年）
  • 按最終用途分類的市場規模、預測和趨勢分析（2021-2033年）
  • 醫療保健提供者
  • 醫院和診所
  • 健康中心及水療中心
  • 居家醫療
  • 其他

第8章：北美靜脈輸液療法市場：國別估算與趨勢分析

  • 各國市場概覽
  • 各國市場：要點
  • 美國
    • 主要國家的趨勢
    • 法律規範
    • 競爭考察
  • 加拿大
    • 主要國家的趨勢
    • 法律規範
    • 競爭考察
  • 墨西哥
    • 主要國家的趨勢
    • 法律規範
    • 競爭考察

第9章 競爭情勢

  • 參與公司概況
  • 企業市場分析
  • 公司分類
  • 策略規劃
  • 公司簡介/列表
    • Baxter
    • B. Braun SE
    • Otsuka Pharmaceutical Co., Ltd.
    • Grifols, SA
    • Vifor Pharma Management Ltd.
    • JW Life Science Corporation
    • Amanta Healthcare
    • NexGen Health
    • Core IV Therapy, LLC
    • Drip Hydration
    • REVIV
    • DriPros IV Hydration Wellness
    • wHydrate
    • Renew Ketamine &Wellness Center
    • R2 Medical Clinic
    • AliveDrip
    • Hydrate IV
    • Hydration Room
Product Code: GVR-4-68040-161-3

North America IV Hydration Therapy Market Summary

The North America IV hydration therapy market size was estimated at USD 1.35 billion in 2025 and is projected to reach USD 2.56 billion by 2033, growing at a CAGR of 8.6% from 2026 to 2033. The market is primarily driven by heightened consumer emphasis on proactive health management, the shift toward preventive wellness, and increasing demand for convenient, on-demand healthcare services.

Post-pandemic health consciousness has significantly accelerated the adoption of intravenous (IV) hydration as a lifestyle and recovery solution. In parallel, the growing incidence of fatigue, migraines, and nutrient deficiencies has expanded the therapeutic scope of IV therapy beyond traditional clinical use.

The North America IV hydration therapy industry is rising, owing to the increasing prevalence of chronic diseases such as cancer and diabetes. According to the CDC estimates of February 2024, around 129 million people in the US have at least 1 major chronic disease, creating a strong demand for effective healthcare solutions. IV hydration therapy is a crucial player, offering a direct and quick way to address the consequences and management of chronic diseases. It becomes a valuable tool in improving the well-being of individuals facing these conditions. As chronic diseases become more common, the market is stepping up to provide specialized care and support for those who need it.

Increasing awareness of the benefits of IV hydration therapies among North America's population is boosting the market growth. According to the National Institute of Health and Care Excellence, numerous adult patients require Intravenous (IV) fluid therapy to address to fluid and electrolyte balance. IV therapy is a therapeutic intervention that delivers fluids directly into the bloodstream to restore hydration and revitalize the body. Remarkably, IV hydration offers a faster and more complete absorption of vitamins, electrolytes, and antioxidants than oral intake, as it avoids the digestive system.

IV hydration therapy is utilized across multiple clinical areas to ensure rapid and effective fluid and electrolyte management. In emergency and critical care, it provides immediate resuscitation for trauma, shock, sepsis, and acute dehydration. For gastrointestinal disorders, it helps manage fluid loss from severe vomiting, diarrhea, or inflammatory bowel conditions. Post-surgical care relies on IV therapy to maintain fluid balance, deliver medications, and support recovery when oral intake is limited. In oncology, it prevents dehydration and fatigue during chemotherapy and radiation, while in chronic disease management, it supports patients with diabetes, renal, or cardiovascular conditions who have restricted oral intake.

The increasing demand for IV hydration therapy is also driven by the shift toward convenient, personalized wellness options that go beyond traditional clinical care. For instance, in August 2025, AquaPulse IV introduced mobile IV therapy services in Fredericksburg, Virginia. The service provides customized hydration and vitamin infusions directly to clients' homes, workplaces, or events, administered by licensed medical professionals. Such development shows how IV therapy is becoming part of a lifestyle and preventive health approach, offering people quick recovery, energy boosts, and immune support in environments that fit their daily routines. These on-demand models highlight the rising focus on accessibility and patient-centered care in wellness services.

North America IV Hydration Therapy Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends across sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the North America IV hydration therapymarket report based on service, component, provider type, end use, and regions.

  • Service Outlook (Revenue, USD Million, 2021 - 2033)
  • Immune Boosters
  • Energy Boosters
  • Hydration
  • Beauty/ Aesthetics
  • Detoxification
  • Longevity/ Antiaging
  • Performance/ Athletics
  • Migraine & Pain Relief
  • Stress/Sleep/Mood Support
  • Flu/Stomach
  • Others
  • Component Outlook (Revenue, USD Million, 2021 - 2033)
  • Medicated
  • Non-medicated
  • Provider Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Mobile Providers
  • Physical Providers
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals & Clinics
  • Wellness Centers and Spas
  • Home Healthcare
  • Others
  • Country Outlook (Revenue, USD Million, 2021 - 2033)
  • U.S.
  • Canada
  • Mexico

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Service
    • 1.2.2. Component
    • 1.2.3. Provider Type
    • 1.2.4. End use
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Growing demand for quick rehydration and recovery solutions
      • 3.2.1.2. Increasing adoption of wellness and preventive healthcare trends
      • 3.2.1.3. Rising popularity of IV nutrient therapy for beauty, skin rejuvenation, and anti-aging benefits
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Risk of side effects, including infections, vein inflammation, or allergic reactions
      • 3.2.2.2. High cost of treatments compared to oral supplements and conventional care
      • 3.2.2.3. Limited insurance coverage, making therapies less accessible to many patients
    • 3.2.3. Industry Opportunity Analysis
    • 3.2.4. Industry Challenge Analysis
    • 3.2.5. Pricing Analysis
    • 3.2.6. Emerging Trends
  • 3.3. Business Environment Analysis
    • 3.3.1. Porter's Five Forces Analysis
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTLE Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic and Social landscape
      • 3.3.2.3. Technological landscape
      • 3.3.2.4. Environmental landscape
      • 3.3.2.5. Legal Landscape

Chapter 4. North America IV Hydration Therapy Market: Service Estimates & Trend Analysis

  • 4.1. Service Segment Dashboard
  • 4.2. Service Market Share Movement Analysis, 2025 & 2033
  • 4.3. Market Size & Forecasts and Trend Analysis, by Service, 2021 to 2033 (USD Million)
  • 4.4. Immune Boosters
    • 4.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Energy Boosters
    • 4.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Hydration
    • 4.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.7. Beauty/ Aesthetics
    • 4.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.8. Detoxification
    • 4.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.9. Longevity/ Antiaging
    • 4.9.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.10. Performance/ Athletics
    • 4.10.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.11. Migraine & Pain Relief
    • 4.11.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.12. Stress/Sleep/Mood Support
    • 4.12.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.13. Flu/Stomach
    • 4.13.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.14. Others
    • 4.14.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. North America IV Hydration Therapy Market: Component Estimates & Trend Analysis

  • 5.1. Component Segment Dashboard
  • 5.2. Component Market Share Movement Analysis, 2025 & 2033
  • 5.3. Market Size & Forecasts and Trend Analysis, by Component, 2021 to 2033 (USD Million)
  • 5.4. Medicated
    • 5.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Non-Medicated
    • 5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. North America IV Hydration Therapy Market: Provider Type Estimates & Trend Analysis

  • 6.1. Provider Type Dashboard
  • 6.2. Provider Type Market Share Movement Analysis, 2025& 2033
  • 6.3. Market Size & Forecasts and Trend Analysis, by Provider Type, 2021 to 2033 (USD Million)
  • 6.4. Mobile Providers
    • 6.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Physical Providers
    • 6.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. North America IV Hydration Therapy Market: End Use Estimates & Trend Analysis

  • 7.1. End use Segment Dashboard
  • 7.2. End use Market Share Movement Analysis, 2025 & 2033
  • 7.3. Market Size & Forecasts and Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 7.4. Healthcare Providers
    • 7.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5. Hospitals & Clinics
    • 7.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Wellness Centers & Spas
    • 7.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7. Home Healthcare
    • 7.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.8. Others
    • 7.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. North America IV Hydration Therapy Market: Country Estimates & Trend Analysis

  • 8.1. Country Market Dashboard
  • 8.2. Country Market: Key Takeaways
  • 8.3. U.S.
    • 8.3.1. Key country dynamic
    • 8.3.2. Regulatory framework
    • 8.3.3. Competitive insights
    • 8.3.4. U.S. IV Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.4. Canada
    • 8.4.1. Key country dynamic
    • 8.4.2. Regulatory framework
    • 8.4.3. Competitive insights
    • 8.4.4. Canada IV Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.5. Mexico
    • 8.5.1. Key country dynamic
    • 8.5.2. Regulatory framework
    • 8.5.3. Competitive insights
    • 8.5.4. Mexico IV Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Participant Overview
  • 9.2. Company Market Position Analysis
  • 9.3. Company Categorization
  • 9.4. Strategy Mapping
  • 9.5. Company Profiles/Listing
    • 9.5.1. Baxter
      • 9.5.1.1. Overview
      • 9.5.1.2. Financial performance
      • 9.5.1.3. Product benchmarking
      • 9.5.1.4. Strategic initiatives
    • 9.5.2. B. Braun SE
      • 9.5.2.1. Overview
      • 9.5.2.2. Financial performance
      • 9.5.2.3. Product benchmarking
      • 9.5.2.4. Strategic initiatives
    • 9.5.3. Otsuka Pharmaceutical Co., Ltd.
      • 9.5.3.1. Overview
      • 9.5.3.2. Financial performance
      • 9.5.3.3. Product benchmarking
      • 9.5.3.4. Strategic initiatives
    • 9.5.4. Grifols, S.A.
      • 9.5.4.1. Overview
      • 9.5.4.2. Financial performance
      • 9.5.4.3. Product benchmarking
      • 9.5.4.4. Strategic initiatives
    • 9.5.5. Vifor Pharma Management Ltd.
      • 9.5.5.1. Overview
      • 9.5.5.2. Financial performance
      • 9.5.5.3. Product benchmarking
      • 9.5.5.4. Strategic initiatives
    • 9.5.6. JW Life Science Corporation
      • 9.5.6.1. Overview
      • 9.5.6.2. Financial performance
      • 9.5.6.3. Product benchmarking
      • 9.5.6.4. Strategic initiatives
    • 9.5.7. Amanta Healthcare
      • 9.5.7.1. Overview
      • 9.5.7.2. Financial performance
      • 9.5.7.3. Product benchmarking
      • 9.5.7.4. Strategic initiatives
    • 9.5.8. NexGen Health
      • 9.5.8.1. Overview
      • 9.5.8.2. Financial performance
      • 9.5.8.3. Product benchmarking
      • 9.5.8.4. Strategic initiatives
    • 9.5.9. Core IV Therapy, LLC
      • 9.5.9.1. Overview
      • 9.5.9.2. Financial performance
      • 9.5.9.3. Product benchmarking
      • 9.5.9.4. Strategic initiatives
    • 9.5.10. Drip Hydration
      • 9.5.10.1. Overview
      • 9.5.10.2. Financial performance
      • 9.5.10.3. Product benchmarking
      • 9.5.10.4. Strategic initiatives
    • 9.5.11. REVIV
      • 9.5.11.1. Overview
      • 9.5.11.2. Financial performance
      • 9.5.11.3. Product benchmarking
      • 9.5.11.4. Strategic initiatives
    • 9.5.12. DriPros IV Hydration Wellness
      • 9.5.12.1. Overview
      • 9.5.12.2. Financial performance
      • 9.5.12.3. Product benchmarking
      • 9.5.12.4. Strategic initiatives
    • 9.5.13. wHydrate
      • 9.5.13.1. Overview
      • 9.5.13.2. Financial performance
      • 9.5.13.3. Product benchmarking
      • 9.5.13.4. Strategic initiatives
    • 9.5.14. Renew Ketamine & Wellness Center
      • 9.5.14.1. Overview
      • 9.5.14.2. Financial performance
      • 9.5.14.3. Product benchmarking
      • 9.5.14.4. Strategic initiatives
    • 9.5.15. R2 Medical Clinic
      • 9.5.15.1. Overview
      • 9.5.15.2. Financial performance
      • 9.5.15.3. Product benchmarking
      • 9.5.15.4. Strategic initiatives
    • 9.5.16. AliveDrip
      • 9.5.16.1. Overview
      • 9.5.16.2. Financial performance
      • 9.5.16.3. Product benchmarking
      • 9.5.16.4. Strategic initiatives
    • 9.5.17. Hydrate IV
      • 9.5.17.1. Overview
      • 9.5.17.2. Financial performance
      • 9.5.17.3. Product benchmarking
      • 9.5.17.4. Strategic initiatives
    • 9.5.18. Hydration Room
      • 9.5.18.1. Overview
      • 9.5.18.2. Financial performance
      • 9.5.18.3. Product benchmarking
      • 9.5.18.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 List of secondary data sources
  • Table 3 North America IV Hydration Therapy market, by country, 2021 - 2033 (USD Million)
  • Table 4 North America IV Hydration Therapy market, by component, 2021 - 2033 (USD Million)
  • Table 5 North America IV Hydration Therapy market, by service, 2021 - 2033 (USD Million)
  • Table 6 North America IV Hydration Therapy market, by provider type, 2021 - 2033 (USD Million)
  • Table 7 North America IV Hydration Therapy market, by end use, 2021 - 2033 (USD Million)
  • Table 8 U.S. IV Hydration Therapy market, by component, 2021 - 2033 (USD Million)
  • Table 9 U.S. IV Hydration Therapy market, by service, 2021 - 2033 (USD Million)
  • Table 10 U.S. IV Hydration Therapy market, by provider type, 2021 - 2033 (USD Million)
  • Table 11 U.S. IV Hydration Therapy market, by end use, 2021 - 2033 (USD Million)
  • Table 12 Canada IV Hydration Therapy market, by component, 2021 - 2033 (USD Million)
  • Table 13 Canada IV Hydration Therapy market, by service, 2021 - 2033 (USD Million)
  • Table 14 Canada IV Hydration Therapy market, by provider type, 2021 - 2033 (USD Million)
  • Table 15 Canada IV Hydration Therapy market, by end use, 2021 - 2033 (USD Million)
  • Table 16 Mexico IV Hydration Therapy market, by component, 2021 - 2033 (USD Million)
  • Table 17 Mexico IV Hydration Therapy market, by service, 2021 - 2033 (USD Million)
  • Table 18 Mexico IV Hydration Therapy market, by provider type, 2021 - 2033 (USD Million)
  • Table 19 Mexico IV Hydration Therapy market, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Market formulation & validation
  • Fig. 4 North America IV Hydration Therapy market: Market outlook
  • Fig. 5 North America IV Hydration Therapy market: Segment outlook
  • Fig. 6 North America IV Hydration Therapy market: Competitive landscape outlook
  • Fig. 7 Parent market outlook
  • Fig. 8 North America IV Hydration Therapy Market Driver Impact
  • Fig. 9 North America IV Hydration Therapy market Restraint impact
  • Fig. 10 North America IV Hydration Therapy market, Service outlook key takeaways (USD Million)
  • Fig. 11 North America IV Hydration Therapy market: Service movement analysis (USD Million)
  • Fig. 12 Immune Boosters market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 13 Energy Boosters market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 14 Hydration market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 15 Beauty/ Aesthetics market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 16 Detoxification market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 17 Longevity/ Antiaging market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 18 Performance/ Athletics market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 19 Migraine & Pain Relief market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 20 Stress/Sleep/Mood Support market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 21 Flu/Stomach market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 23 North America IV Hydration Therapy market, component outlook: Key takeaways, (USD Million)
  • Fig. 24 North America IV Hydration Therapy market: component movement analysis, (USD Million)
  • Fig. 25 Medicated market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Non-Medicated market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 North America IV Hydration Therapy market, provider type outlook key takeaways (USD Million)
  • Fig. 28 North America IV Hydration Therapy market: provider type movement analysis, (USD Million)
  • Fig. 29 Mobile Providers market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 Physical Providers market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 North America IV Hydration Therapy market, end use outlook key takeaways (USD Million)
  • Fig. 32 North America IV Hydration Therapy market: end use movement analysis, (USD Million)
  • Fig. 33 Hospitals & Clinics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 Wellness Centers & Spas market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Home Healthcare market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 Country marketplace: Key takeaways
  • Fig. 38 North America IV Hydration Therapy market: Country outlook, 2025 & 2033
  • Fig. 39 U.S. IV Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 40 Canada IV Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 Mexico IV Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)